Spectrum Vascular

Executive Summary

Spectrum Vascular is a private medical device company based in San Jose, CA, focused on developing innovative technologies for the treatment of vascular diseases. Founded in 2019, the company operates at the platform stage, building a pipeline of novel devices aimed at addressing significant unmet needs in cardiovascular and peripheral vascular care. With a team of 50-200 employees, Spectrum Vascular leverages its expertise in device engineering and clinical development to advance products that could improve patient outcomes and procedural efficiency. While the company has not yet disclosed specific financials or commercial products, its positioning in the vascular space and platform approach suggest potential for multiple applications. The absence of publicly available clinical data or regulatory milestones indicates an early-stage profile, but the company's focus on a high-need area and its location in a medtech hub provide a foundation for future growth. Key risks include technology validation, regulatory hurdles, and competition from established players. Successful execution could lead to significant value creation, but near-term visibility remains limited.

Upcoming Catalysts (preview)

• Q2 2027Initiation of First-in-Human Clinical Trial for Lead Device60% success
• Q4 2026FDA Breakthrough Device Designation Granted50% success
• Q1 2027Strategic Partnership or Licensing Agreement with Major Cardiovascular Company40% success